Free Trial

Ocugen (OCGN) Short Interest Ratio & Short Volume

$1.83
-0.12 (-6.15%)
(As of 07/17/2024 ET)

Ocugen Short Interest Data

Current Short Interest
53,120,000 shares
Previous Short Interest
49,060,000 shares
Change Vs. Previous Month
+8.28%
Dollar Volume Sold Short
$82.34 million
Short Interest Ratio
7.6 Days to Cover
Last Record Date
June 30, 2024
Outstanding Shares
257,350,000 shares
Percentage of Shares Shorted
20.64%
Today's Trading Volume
5,893,978 shares
Average Trading Volume
7,456,611 shares
Today's Volume Vs. Average
79%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Ocugen ?

Sign up to receive the latest short interest report for Ocugen and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

OCGN Short Interest Over Time

OCGN Days to Cover Over Time

OCGN Percentage of Float Shorted Over Time

Ocugen Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/30/202453,120,000 shares $82.34 million +8.3%N/A7.6 $1.55
6/15/202449,060,000 shares $69.67 million +1.6%N/A5.9 $1.42
5/31/202448,310,000 shares $83.58 million -7.2%N/A5.6 $1.73
5/15/202452,080,000 shares $102.08 million +8.8%N/A5.7 $1.96
4/30/202447,890,000 shares $63.21 million +5.9%N/A4.9 $1.32
4/15/202445,230,000 shares $71.92 million +4.0%N/A5 $1.59
3/31/202443,480,000 shares $71.31 million +22.8%N/A5.3 $1.64
3/15/202435,400,000 shares $38.23 million -3.4%N/A4.5 $1.08
2/29/202436,650,000 shares $34.30 million +50.5%N/A6.7 $0.94
2/15/202424,360,000 shares $18.17 million +2.7%N/A5 $0.75
1/31/202423,710,000 shares $12.71 million -8.6%N/A9.3 $0.54
1/15/202425,950,000 shares $15.53 million +10.4%N/A10.2 $0.60
12/31/202323,510,000 shares $13.52 million +5.6%N/A9.6 $0.58
12/15/202322,270,000 shares $8.41 million -6.5%N/A12.3 $0.38
11/30/202323,820,000 shares $9.21 million -5.4%N/A17.3 $0.39
11/15/202325,180,000 shares $9.56 million +2.0%N/A16.6 $0.38
10/31/202324,690,000 shares $9.08 million -2.6%N/A11.7 $0.37
10/15/202325,360,000 shares $10.61 million +0.6%N/A10 $0.42
9/30/202325,220,000 shares $10.09 million +3.7%N/A7.9 $0.40
9/15/202324,330,000 shares $9.96 million -4.7%N/A5.6 $0.41
8/31/202325,520,000 shares $11.00 million +3.4%N/A4.7 $0.43
8/15/202324,680,000 shares $11.76 million -0.6%N/A3.4 $0.48
7/31/202324,830,000 shares $15.27 million -2.3%N/A3.3 $0.62
7/15/202325,410,000 shares $14.83 million -5.7%N/A3.2 $0.58
6/30/202326,940,000 shares $14.63 million -27.7%N/A3.5 $0.54
6/15/202337,250,000 shares $19.99 million -10.9%N/A5 $0.54
5/31/202341,790,000 shares $19.22 million +2.5%N/A5.6 $0.46
5/15/202340,760,000 shares $29.92 million +2.0%N/A6.2 $0.73
4/30/202339,950,000 shares $28.51 million +6.4%N/A6.4 $0.71
4/15/202337,540,000 shares $30.04 million +1.2%N/A6.1 $0.80
3/31/202337,100,000 shares $31.65 million -27.1%N/A5.5 $0.85
3/15/202350,880,000 shares $46.88 million +2.9%N/A7.5 $0.92
2/28/202349,470,000 shares $49.28 million +4.4%N/A8.6 $1.00
2/15/202347,390,000 shares $52.13 million +5.4%N/A9 $1.10
1/31/202344,970,000 shares $57.11 million +0.9%N/A8.6 $1.27
1/15/202344,590,000 shares $57.97 million +9.7%N/A8.8 $1.30
12/30/202240,650,000 shares $52.85 million +0.3%N/A8.3 $1.30
12/15/202240,530,000 shares $58.77 million +0.5%N/A8.8 $1.45
11/30/202240,350,000 shares $62.95 million -2.8%N/A8.6 $1.56
11/15/202241,530,000 shares $71.43 million -4.0%N/A8.6 $1.72
I’m giving you the name of this investment for free (Ad)

What people don’t know is that Roivant is capitalizing on a wealth secret that goes back over a century. There are a few other public companies who are as well. Only you don’t know it… because it’s not something they openly talk about. That’s why I made this presentation. I want to expose you to a wealth-building secret that you deserve to benefit from.

You deserve to see this for your own good.
10/31/202243,270,000 shares $74.42 million +0.1%N/A8.6 $1.72
10/15/202243,210,000 shares $67.41 million -1.3%N/A8.6 $1.56
9/30/202243,790,000 shares $77.95 million +6.6%N/A8.5 $1.78
9/15/202241,080,000 shares $96.95 million -9.4%N/A7.8 $2.36
8/31/202245,340,000 shares $116.98 million -7.6%N/A8.1 $2.58
8/15/202249,070,000 shares $141.32 million -11.9%N/A8.2 $2.88
7/31/202255,700,000 shares $143.71 million +3.3%N/A8.7 $2.58
7/15/202253,940,000 shares $139.17 million -1.1%N/A8.1 $2.58
6/30/202254,540,000 shares $123.81 million -0.3%N/A7.8 $2.27
6/15/202254,690,000 shares $113.76 million -8.4%N/A7.6 $2.08
5/31/202259,720,000 shares $141.54 million +3.2%N/A7.2 $2.37
5/15/202257,850,000 shares $121.49 million -1.3%N/A5.3 $2.10
4/30/202258,600,000 shares $128.33 million +8.7%N/A5.5 $2.19
4/15/202253,910,000 shares $148.79 million -2.4%N/A4.7 $2.76
3/31/202255,230,000 shares $182.26 million +14.7%N/A4.5 $3.30
3/15/202248,140,000 shares $130.46 million -6.1%N/A3.6 $2.71
2/28/202251,290,000 shares $180.54 million -5.9%N/A3.7 $3.52
2/15/202254,510,000 shares $212.59 million -0.8%N/A3.9 $3.90
1/31/202254,940,000 shares $195.04 million +1.2%30.2%3.8 $3.55
1/15/202254,310,000 shares $230.82 million -1.7%27.9%1.9 $4.25
12/31/202155,220,000 shares $251.25 million +1.7%28.4%1.7 $4.55
12/15/202154,300,000 shares $294.31 million +9.8%27.8%1.6 $5.42
11/30/202149,470,000 shares $313.64 million +5.4%25.3%1.5 $6.34
11/15/202146,930,000 shares $389.52 million -14.3%24.1%1.5 $8.30
10/29/202154,770,000 shares $648.48 million -3.9%28.2%1.8 $11.84
10/15/202156,980,000 shares $493.45 million +7.4%29.4%2.9 $8.66
9/30/202153,080,000 shares $381.11 million +0.6%27.4%4 $7.18
9/15/202152,750,000 shares $397.21 million +3.3%27.2%3.3 $7.53
8/31/202151,080,000 shares $387.70 million -5.7%26.3%2.4 $7.59
8/13/202154,180,000 shares $402.02 million +1.5%27.9%2 $7.42
7/30/202153,390,000 shares $358.25 million +2.2%27.5%1.6 $6.71
7/15/202152,250,000 shares $332.31 million +3.3%27.0%0.8 $6.36
6/30/202150,590,000 shares $406.24 million +2.6%26.2%0.8 $8.03
6/15/202149,310,000 shares $308.68 million +14.7%25.5%0.7 $6.26
5/28/202142,980,000 shares $375.22 million +12.9%22.2%0.7 $8.73
5/14/202138,080,000 shares $313.40 million +2.8%19.7%0.6 $8.23
4/30/202137,030,000 shares $442.88 million +6.5%19.2%0.5 $11.96
4/15/202134,770,000 shares $239.91 million +28.2%19.0%0.5 $6.90
3/31/202127,130,000 shares $183.13 million +108.4%14.9%0.5 $6.75
3/15/202113,020,000 shares $130.20 million +4.8%7.1%0.1 $10.00
2/26/202112,430,000 shares $99.44 million +52.3%6.8%0.1 $8.00
2/12/20218,160,000 shares $89.68 million -28.0%4.5%0.1 $10.99
1/29/202111,340,000 shares $20.64 million -23.4%7.2%0.1 $1.82
1/15/202114,800,000 shares $32.26 million -16.2%9.5%0.3 $2.18
12/31/202017,660,000 shares $34.79 million +254.6%11.3%0.4 $1.97
12/15/20204,980,000 shares $1.47 million +19.7%3.2%0.1 $0.30
11/30/20204,160,000 shares $1.24 million -19.1%2.7%0.5 $0.30
11/15/20205,140,000 shares $1.48 million -5.7%3.3%0.6 $0.29
10/30/20205,450,000 shares $1.59 million -11.5%3.5%0.7 $0.29
10/15/20206,160,000 shares $2.06 million +0.8%4.0%0.2 $0.33
I’m giving you the name of this investment for free (Ad)

I want to help you achieve that right by accessing a new business model in America that has been unlocked by a billionaire who may end up sitting in Trump’s cabinet.

You deserve to see this for your own good.
9/30/20206,110,000 shares $1.89 million +35.8%4.7%0.2 $0.31
9/15/20204,500,000 shares $1.48 million -9.1%3.5%0.1 $0.33
8/31/20204,950,000 shares $1.72 million -18.2%3.8%0.1 $0.35
8/14/20206,050,000 shares $3.42 million -8.3%4.7%0.2 $0.56
7/31/20206,600,000 shares $3.40 million +6,022.5%5.1%0.2 $0.52
7/15/2020107,800 shares $23,090.76 -66.8%0.1%0 $0.21
6/30/2020325,100 shares $71,652.04 +98.1%0.3%0 $0.22
6/15/2020164,100 shares $44,307.00 -47.3%0.2%0 $0.27
5/29/2020311,200 shares $96,472.00 +43.3%0.5%0 $0.31
5/15/2020217,100 shares $65,108.29 -58.7%0.3%0 $0.30
4/30/2020525,400 shares $164,450.20 -4.8%0.8%0.1 $0.31
4/15/2020551,900 shares $231,798.00 -8.8%1.2%0.2 $0.42
3/31/2020605,200 shares $187,612.00 -10.6%1.3%0.2 $0.31
3/13/2020676,700 shares $209,777.00 -11.0%1.4%0.3 $0.31
2/28/2020760,500 shares $220,545.00 -42.0%1.6%0.1 $0.29
2/14/20201,310,000 shares $524,000.00 -17.6%2.8%0.2 $0.40
1/31/20201,590,000 shares $667,800.00 +3.3%3.4%0.2 $0.42
1/15/20201,540,000 shares $939,400.00 -24.9%14.9%0.2 $0.61
12/31/20192,050,000 shares $1.37 million No Change26.7%0.3 $0.67

OCGN Short Interest - Frequently Asked Questions

What is Ocugen's current short interest?

Short interest is the volume of Ocugen shares that have been sold short but have not yet been closed out or covered. As of June 30th, traders have sold 53,120,000 shares of OCGN short. Learn More on Ocugen's current short interest.

What is a good short interest ratio for Ocugen?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. OCGN shares currently have a short interest ratio of 8.0. Learn More on Ocugen's short interest ratio.

Which institutional investors are shorting Ocugen?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Ocugen: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Ocugen's short interest increasing or decreasing?

Ocugen saw a increase in short interest during the month of June. As of June 30th, there was short interest totaling 53,120,000 shares, an increase of 8.3% from the previous total of 49,060,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Ocugen's short interest compare to its competitors?

Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Ocugen: aTyr Pharma, Inc. (0.50%), Recursion Pharmaceuticals, Inc. (23.56%), Novavax, Inc. (21.03%), Neumora Therapeutics, Inc. (13.38%), BioCryst Pharmaceuticals, Inc. (8.66%), 4D Molecular Therapeutics, Inc. (19.13%), Sana Biotechnology, Inc. (21.58%), Vir Biotechnology, Inc. (5.33%), Tarsus Pharmaceuticals, Inc. (22.39%), Immatics (11.27%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.71 billion), TC Energy Co. ($2.95 billion), Moderna, Inc. ($2.63 billion), Royal Caribbean Cruises Ltd. ($2.53 billion), Paychex, Inc. ($2.03 billion), Cencora, Inc. ($2.03 billion), Tractor Supply ($1.91 billion), Rivian Automotive, Inc. ($1.78 billion), Chesapeake Energy Co. ($1.50 billion), and United Therapeutics Co. ($1.40 billion). View all of the most shorted stocks.

What does it mean to sell short Ocugen stock?

Short selling OCGN is an investing strategy that aims to generate trading profit from Ocugen as its price is falling. OCGN shares are trading up $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Ocugen?

A short squeeze for Ocugen occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of OCGN, which in turn drives the price of the stock up even further.

How often is Ocugen's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OCGN, twice per month. The most recent reporting period available is June, 30 2024.



This page (NASDAQ:OCGN) was last updated on 7/17/2024 by MarketBeat.com Staff

From Our Partners